Description:

S0502 Off Treatment Notice S0502 Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor NCT00324987 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FCCFD537-4859-4344-E034-0003BA3F9857

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FCCFD537-4859-4344-E034-0003BA3F9857
Keywords:
  1. 9/19/12 9/19/12 -
  2. 1/8/15 1/8/15 - Martin Dugas
  3. 3/24/15 3/24/15 - Martin Dugas
Uploaded on:

March 24, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Gastrointestinal Stromal Tumor NCT00324987

No Instruction available.

  1. StudyEvent: S0502 Off Treatment Notice
    1. No Instruction available.
Header
Off Treatment
Off Treatment Reason (select one:)
Was treatment termination medically required (For any adverse event,)
Was reason due to adverse event/side effects/complications (For any patient refusal,)
Will patient receive further treatment?
Vital Status

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial